Galecto Inc expected to post a loss of 62 cents a share - Earnings Preview

Damora Therapeutics

25/04/2023 12:03

* Galecto Inc  GLTO.OQ   GLTO.O  is expected to report
results on
April 27 (estimated).
    * 
    * ​Refinitiv's mean analyst estimate for Galecto Inc is for
a loss
of 62 cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 5 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had fallen by
about 18.7%
in the last three months. ​
    * Wall Street's median 12-month price target for Galecto Inc
is
$12​, above​ its last closing price of $2.06. ​​​

This summary was machine generated April 25 at 11:03 GMT.  All
figures in US dollars  unless otherwise stated